Stanford University
Showing 381-390 of 824 Results
-
Hiroyuki Shimada
Professor of Pathology and, by courtesy, of Pediatrics
BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials. -
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason. -
Chungheon Shin
Research Engineer
BioChungheon Shin is the Research Director of the Codiga Resource Recovery Center at Stanford University. His research advances sustainable water and environmental technologies through process intensification, environmental biotechnology, and resource recovery. By integrating biological and physicochemical processes with mechanistic and data-driven computational models, he develops engineering solutions that recover clean water, energy, and valuable resources. His work spans multiple scales, from fundamental reaction kinetics to pilot- and demonstration-scale systems, with a strong emphasis on translating research into real-world applications.
His current research focuses on three complementary areas: process intensification, resource recovery, and digital optimization of water infrastructure. He has led the development of the Staged Anaerobic Fluidized-bed Membrane Bioreactor (SAF-MBR), an energy-positive wastewater treatment technology that has advanced to demonstration scale, and is developing pilot-scale methane-to-protein technologies that convert waste methane into sustainable protein through efficient gas transfer and environmental biotechnology. His research also integrates mechanistic understanding with data-driven modeling to optimize biological treatment processes and accelerate the deployment of next-generation water technologies.
Dr. Shin received his Ph.D. in Environmental Engineering from Inha University in South Korea, where he developed the SAF-MBR under the supervision of Professor Jaehoe Bae and Professor Perry L. McCarty. He subsequently joined the Department of Civil and Environmental Engineering at Stanford University as a postdoctoral scholar under Professor Craig S. Criddle, where he expanded his research in environmental biotechnology, process intensification, and sustainable water infrastructure. -
Gi-Wook Shin
William J. Perry Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of East Asian Languages and Cultures
Current Research and Scholarly InterestsKorean democratization; Korean nationalism; U.S.-Korea relations; North Korean politics; reconciliation and cooperation in Northeast Asia; global talent; multiculturalism; inter-Korean relations
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
